Karkabi Basheer, Meir Gal, Zafrir Barak, Jaffe Ronen, Adawi Salim, Lavi Idit, Flugelman Moshe Y, Shiran Avinoam
Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, 7 Michal St., Haifa, Israel.
Eur Heart J Qual Care Clin Outcomes. 2021 Jul 21;7(4):422-426. doi: 10.1093/ehjqcco/qcaa037.
The evidence are not conclusive that a small incremental increase in door-to-balloon (D2B) time leads to a significant increase in death of ST-elevation myocardial infarction (STEMI) patients. In a previous study, we described a quality improvement intervention that reduced D2B time in 333 patients with STEMI. The aim of the current study was to compare mortality rates of the patients, before and after the intervention.
We examined the survival of 133 consecutive patients with STEMI treated prior to an intervention to decrease D2B time and 200 treated after the intervention. The mortality rate was the same before and after the quality intervention. The median D2B time for the entire cohort was 55 min. The number of patients with D2B time >55 min prior to the intervention was 82/133 (61%) and after the intervention 74/200 (37%) P < 0.00001. Thirty-day mortality among the patients with D2B time ≤55 min was 5/178 (2.8%) and among those with D2B time >55 min was 15/155 (9.7%), P < 0.008. The hazard ratio for 30-day mortality when the D2B time was >55 min was 3.7 (1.3-10.4).
Mortality and non-fatal complications did not differ significantly between STEMI patients before and after a quality improvement intervention. However, the number of patients treated within 55 min from arrival was significantly higher after the intervention; and coronary intervention within this time was associated with a lower death rate.
尚无确凿证据表明门球时间(D2B)小幅增加会导致ST段抬高型心肌梗死(STEMI)患者死亡显著增加。在之前的一项研究中,我们描述了一项质量改进干预措施,该措施缩短了333例STEMI患者的D2B时间。本研究的目的是比较干预前后患者的死亡率。
我们检查了133例在干预降低D2B时间之前接受治疗的连续性STEMI患者和200例干预后接受治疗的患者的生存情况。质量干预前后的死亡率相同。整个队列的D2B时间中位数为55分钟。干预前D2B时间>55分钟的患者数量为82/133(61%),干预后为74/200(37%),P<0.00001。D2B时间≤55分钟的患者30天死亡率为5/178(2.8%),D2B时间>55分钟的患者为15/155(9.7%),P<0.008。当D2B时间>55分钟时,30天死亡率的风险比为3.7(1.3 - 10.4)。
质量改进干预前后,STEMI患者的死亡率和非致命并发症无显著差异。然而,干预后在到达后55分钟内接受治疗的患者数量显著增加;在此时间段内进行冠状动脉介入治疗与较低的死亡率相关。